Effect of phenoxybenzamine and combined administration of iproniazid and tropolone on catecholamine release elicited by renal sympathetic nerve stimulation.
D000818:Animals; D001794:Blood Pressure; D002395:Catecholamines / Q000378:metabolism*; D003508:Cycloheptanes / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D007490:Iproniazid / Q000008:administration & dosage / Q000494:pharmacology*; D007659:Ketones / Q000008:administration & dosage / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000294:innervation / Q000378:metabolism*; D008297:Male; D008780:Methyltransferases / Q000037:antagonists & inhibitors; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D010643:Phenoxybenzamine / Q000008:administration & dosage / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000502:physiology; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D002395:Catecholamines; D003508:Cycloheptanes; D007659:Ketones; D008996:Monoamine Oxidase Inhibitors; D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D007490:Iproniazid; D008780:Methyltransferases; D009638:Norepinephrine